Antibiotic resistance in rectal bacteria of PrEP users
Part of Infections clinical trials.
This study looks at the bacteria found in the rectum of people who take PrEP. It checks if those bacteria are resistant to antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are HIV-negative
- You are currently taking PrEP (a daily pill to prevent HIV)
- You are having a routine rectal swab to check for chlamydia or gonorrhea
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study is for people in Spain who are starting or already taking PrEP pills to prevent HIV. It aims to create a tool that can help predict who might get a sexually transmitted infection while on PrEP, so doctors can offer better monitoring or prevention.
This study tests if combining sexually transmitted infection (STI) testing with HIV prevention medication (PrEP) helps control the HIV epidemic. It is for sexually active women aged 15-39 who live in Rakai and recently participated in a community health survey.
This trial tests whether STI testing during pregnancy helps more women start and stay on PrEP (a daily pill that prevents HIV). If you join, you'll help find better ways to protect both mother and baby from HIV.
This study tests a tiny sensor you swallow that lets your phone know when you take your PrEP pill. It aims to help young men stick to their HIV prevention routine.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
Hear when a new Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.